ITMI971115A0 - - Google Patents
Info
- Publication number
- ITMI971115A0 ITMI971115A0 ITMI971115A ITMI971115A ITMI971115A0 IT MI971115 A0 ITMI971115 A0 IT MI971115A0 IT MI971115 A ITMI971115 A IT MI971115A IT MI971115 A ITMI971115 A IT MI971115A IT MI971115 A0 ITMI971115 A0 IT MI971115A0
- Authority
- IT
- Italy
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI001115A IT1291362B1 (it) | 1997-05-13 | 1997-05-13 | Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi |
| DE69820973T DE69820973T2 (de) | 1997-05-13 | 1998-05-13 | Biphasige arzneimitteldosierungsform aus vielen komponenten, die stoffe enthält, die die verteilung der arzneimittel beeinflussen können |
| PCT/EP1998/002846 WO1998051280A1 (en) | 1997-05-13 | 1998-05-13 | Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs |
| AT98929313T ATE257370T1 (de) | 1997-05-13 | 1998-05-13 | Biphasige arzneimiteldosierungsform aus vielen komponenten, die stoffe enthält, die die verteilung der arzneimittel beeinflussen können |
| JP10544435A JP2001502358A (ja) | 1997-05-13 | 1998-05-13 | 薬物の分配を変化させる事が可能な物質を含む、二相性であり多成分の薬剤の用法 |
| US09/214,813 US6495160B2 (en) | 1997-05-13 | 1998-05-13 | Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs |
| AU79125/98A AU7912598A (en) | 1997-05-13 | 1998-05-13 | Biphasic multicomponent pharmaceutical dosage forms containing substanc es able to modify the partitioning of drugs |
| EP98929313A EP0917457B1 (en) | 1997-05-13 | 1998-05-13 | Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs |
| ES98929313T ES2213908T3 (es) | 1997-05-13 | 1998-05-13 | Formas posologicas farmaceuticas bifasicas multicomponente que contienen sustancias capaces de modificar la particion de medicamentos. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI001115A IT1291362B1 (it) | 1997-05-13 | 1997-05-13 | Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI971115A0 true ITMI971115A0 (US06559137-20030506-C00112.png) | 1997-05-13 |
| ITMI971115A1 ITMI971115A1 (it) | 1998-11-13 |
| IT1291362B1 IT1291362B1 (it) | 1999-01-07 |
Family
ID=11377121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT97MI001115A IT1291362B1 (it) | 1997-05-13 | 1997-05-13 | Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi |
Country Status (9)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116531326A (zh) * | 2023-04-26 | 2023-08-04 | 广东嘉博制药有限公司 | 一种阿普米司特的口服乳剂及其制备方法 |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| IL137559A (en) * | 2000-07-27 | 2006-12-31 | Amnon Sintov | A system for administering drugs through the skin |
| EP1331929A1 (en) * | 2000-11-06 | 2003-08-06 | Samyang Corporation | Transdermal drug delivery system with improved water absorbability and adhesion properties |
| JP4865958B2 (ja) * | 2001-05-23 | 2012-02-01 | 株式会社トクホン | 鎮痛抗炎症局所作用型の貼付剤 |
| JP2003055204A (ja) * | 2001-08-21 | 2003-02-26 | Sansho Iyaku Kk | ユビデカレノン組成物及び同組成物を内容物とするカプセル |
| US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
| US7939098B2 (en) * | 2002-05-23 | 2011-05-10 | Femina Pharma Incorporated | Compositions and method for transmucosal drug delivery and cryoprotection |
| AU2003241134A1 (en) * | 2002-06-20 | 2004-01-06 | Amnon Sintov | Transdermal drug delivery system |
| US7001893B2 (en) * | 2002-10-28 | 2006-02-21 | Council Of Scientific And Industrial Research | Inclusion complex of Rifampicin, an anti-tubercular drug, with β-cyclodextrin or 2-hydroxypropyl β-cyclodextrin and a process thereof |
| US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
| US6635654B1 (en) | 2003-01-09 | 2003-10-21 | Allergan, Inc. | Ophthalmic compositions containing loratadine |
| FR2851918B1 (fr) * | 2003-03-06 | 2006-06-16 | Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication | |
| JP4512700B2 (ja) * | 2003-06-02 | 2010-07-28 | トーアエイヨー株式会社 | アシクロビル含有水溶液製剤 |
| US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
| US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
| ES2409347T3 (es) | 2004-10-21 | 2013-06-26 | Aptalis Pharmatech, Inc. | Composiciones farmacéuticas de sabor enmascarado con agentes porogénicos gastrosolubles |
| US20060105038A1 (en) | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
| JP4866546B2 (ja) * | 2004-12-10 | 2012-02-01 | 久光製薬株式会社 | ジクロフェナク含有乳剤性軟膏剤 |
| US20060177504A1 (en) * | 2005-02-08 | 2006-08-10 | Renjit Sundharadas | Combination pain medication |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| WO2007050724A2 (en) * | 2005-10-26 | 2007-05-03 | Banner Pharmacaps, Inc. | Lipophilic vehicle-based dual controlled release matrix system as capsule fill |
| EP2004203A4 (en) | 2006-03-28 | 2010-03-31 | Javelin Pharmaceuticals Inc | FORMULATIONS OF DICLOFENAC AND CYCLODEXTRIN BETA WITH LOW DOSAGE |
| CN101410012A (zh) * | 2006-03-28 | 2009-04-15 | 杰佛林制药公司 | 低剂量的非甾体抗炎药和β-环糊精的制剂 |
| DE102007034976A1 (de) | 2007-07-26 | 2009-01-29 | Bayer Healthcare Ag | Arzneimittel zur transdermalen Anwendung bei Tieren |
| KR101517415B1 (ko) * | 2008-05-14 | 2015-05-07 | 에스케이바이오팜 주식회사 | 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물 |
| NZ596515A (en) | 2009-05-29 | 2014-03-28 | Cydex Pharmaceuticals Inc | Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same |
| US11020363B2 (en) | 2009-05-29 | 2021-06-01 | Cydex Pharmaceuticals, Inc. | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same |
| BR112012007110A2 (pt) | 2009-10-01 | 2021-08-31 | Aptalis Pharmatech, Inc. | Composição farmacêutica sólida, comprimido de desintegração oral e composição farmacêutica líquida substancialmente não aquosa |
| KR101765357B1 (ko) | 2009-12-02 | 2017-08-04 | 아데어 파마수티컬스 에스.알.엘. | 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물 |
| KR20130106441A (ko) * | 2011-01-31 | 2013-09-27 | 와커 헤미 아게 | 지용성 물질을 포함하는 수용액의 제조방법 |
| HRP20211377T1 (hr) | 2011-11-23 | 2022-01-07 | Therapeuticsmd, Inc. | Prirodne kombinirane hormonske supstitucijske formulacije i terapije |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130251644A1 (en) * | 2012-03-22 | 2013-09-26 | Precision Dermatology, Inc. | Cyclodextrin-Based Microemulsions, and Dermatological Uses Thereof |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| CA2947767A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| CA2951284A1 (en) | 2014-07-29 | 2016-02-04 | Therapeuticsmd, Inc. | Transdermal cream |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| JP2019513709A (ja) | 2016-04-01 | 2019-05-30 | セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． | ステロイドホルモン薬学的組成物 |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
| EP4112041A1 (en) * | 2021-06-30 | 2023-01-04 | GSK Consumer Healthcare SARL | Micellar solution comprising diclofenac |
| WO2023111296A1 (en) * | 2021-12-17 | 2023-06-22 | Basf Se | Composition comprising an antimicrobial agent and a carboxamide |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6016917A (ja) * | 1983-07-08 | 1985-01-28 | Yamanouchi Pharmaceut Co Ltd | 塩酸ニカルジピンまたはニフエジピンの軟膏剤 |
| DE3406497A1 (de) * | 1984-02-23 | 1985-09-05 | Mueller Bernhard Willi Werner | Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung |
| JPH06104624B2 (ja) * | 1986-05-07 | 1994-12-21 | 太郎 小木曽 | 経皮吸収剤 |
| DE3827561C1 (US06559137-20030506-C00112.png) * | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
| AU6974191A (en) * | 1989-12-20 | 1991-07-18 | Schering Corporation | Stable cream and lotion bases for lipophilic drug compositions |
| US5407810A (en) * | 1993-08-20 | 1995-04-18 | Genentech, Inc. | Aqueous multiple-phase isolation of polypeptide |
| WO1995034527A1 (fr) * | 1994-06-16 | 1995-12-21 | Kao Corporation | Ester d'acide gras d'un alcool polyhydrique etherifie |
| US5747058A (en) * | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
-
1997
- 1997-05-13 IT IT97MI001115A patent/IT1291362B1/it active IP Right Grant
-
1998
- 1998-05-13 AU AU79125/98A patent/AU7912598A/en not_active Abandoned
- 1998-05-13 DE DE69820973T patent/DE69820973T2/de not_active Expired - Fee Related
- 1998-05-13 ES ES98929313T patent/ES2213908T3/es not_active Expired - Lifetime
- 1998-05-13 JP JP10544435A patent/JP2001502358A/ja active Pending
- 1998-05-13 US US09/214,813 patent/US6495160B2/en not_active Expired - Fee Related
- 1998-05-13 EP EP98929313A patent/EP0917457B1/en not_active Expired - Lifetime
- 1998-05-13 WO PCT/EP1998/002846 patent/WO1998051280A1/en active IP Right Grant
- 1998-05-13 AT AT98929313T patent/ATE257370T1/de not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116531326A (zh) * | 2023-04-26 | 2023-08-04 | 广东嘉博制药有限公司 | 一种阿普米司特的口服乳剂及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001502358A (ja) | 2001-02-20 |
| ATE257370T1 (de) | 2004-01-15 |
| EP0917457B1 (en) | 2004-01-07 |
| IT1291362B1 (it) | 1999-01-07 |
| US6495160B2 (en) | 2002-12-17 |
| DE69820973T2 (de) | 2004-12-23 |
| US20020034539A1 (en) | 2002-03-21 |
| EP0917457A1 (en) | 1999-05-26 |
| DE69820973D1 (de) | 2004-02-12 |
| ES2213908T3 (es) | 2004-09-01 |
| ITMI971115A1 (it) | 1998-11-13 |
| WO1998051280A1 (en) | 1998-11-19 |
| AU7912598A (en) | 1998-12-08 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted |